Company Overview: Arch Biopartners Inc. (TSXV: ARCH) is a biotechnology company focused on developing innovative therapies for acute kidney injury (AKI) and chronic kidney disease (CKD). The company is advancing an integrated drug development program aimed at addressing inflammation- and toxin-induced kidney damage.  CXApp Inc. (NASDAQ: CXAI)  is a technology company focused on transforming employee workplace experiences through its AI-powered CXAI platform. Headquartered in the San Francisco Bay Area, the company operates at the intersection of customer experience (CX) and artificial intelligence (AI), delivering digital workplace solutions that enhance interactions across people, places, and connected assets. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks. 

Global Markets Wrap-Up

U.S. equity markets ended the week on a weaker note, with most major indices closing lower amid broad-based selling pressure. The S&P 500 declined 0.21% to finish at 7,584.31, as losses across several key sectors weighed on overall market performance. The technology-heavy NASDAQ Composite fell 0.53% to 26,830.96, pressured by continued weakness in growth-oriented and artificial intelligence-related stocks. In contrast, the Russell 2000 outperformed its larger-cap peers, advancing 0.55% to close at 2,935.33, reflecting renewed investor interest in small-cap companies and broader participation across the market.

In Canada, the S&P/TSX Venture Composite Index advanced 0.91% on a week-to-date basis to close at 1,020.76, reflecting strengthening short-term momentum while preserving its broader upward trend. Gains were primarily driven by the consumer non-cyclicals, industrials, technology, basic materials, and financials sectors, highlighting selective investor interest in defensive and economically resilient areas of the market. However, ongoing weakness in the energy sector continued to weigh on overall performance and limited broader market participation. The mixed sector backdrop suggests that, while the underlying market structure remains constructive, investor sentiment is still somewhat cautious, with market participants looking for stronger and more sustained buying activity before embracing a more aggressive risk-on stance.

Past performance is not a reliable indicator of future performance.